# Promising Results of an Exclusive Radiotherapy Treatment of an Inoperable Giant Eyelid Sebaceous Carcinoma

**Authors:** Asmae Hamdan, Salma El Baz, Hanan El Kacemi, Tayeb Kebdani, Khalid Hassouni

PMC · DOI: 10.7759/cureus.61592 · Cureus · 2024-06-03

## TL;DR

A 71-year-old man with an inoperable eyelid cancer was successfully treated with radiotherapy and showed no recurrence after two years.

## Contribution

Demonstrates the effectiveness of exclusive radiotherapy for inoperable eyelid sebaceous carcinoma.

## Key findings

- The patient received 70 Gy of intensity-modulated radiotherapy in 35 fractions.
- After 24 months, there was no local recurrence of the tumor.

## Abstract

Eyelid sebaceous carcinoma is a rare malignant tumor. Surgical excision is generally the standard curative treatment. However, in cases where surgery is not possible due to locally advanced tumors, definitive radiotherapy can be considered an option. A 71-year-old man presented with a history of eyelid sebaceous carcinoma dating back two years. The tumor, measuring 93 x 55 x 56 mm and located on the right upper eyelid, was not surgically resected. He was then treated with intensity-modulated radiotherapy, receiving a total dose of 70 Gy in 35 fractions. After 24 months, the patient shows no local recurrence.

## Full-text entities

- **Diseases:** Eyelid sebaceous carcinoma (MESH:D005142), malignant tumor (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11221620/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11221620/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC11221620/full.md

---
Source: https://tomesphere.com/paper/PMC11221620